Awakn Unveils Q3 Results, Touts Revenue Growth, R&D Progress, Commercial Plans – Awakn Life Sciences (OTC:AWKNF)
Psychedelics biotech Awakn Life Sciences Corp. AWKNF shared its financial results and business highlights for a three-month period that ended Oct. 31, 2022. Financials showed: Revenue of $314.827 (CA$430,504)…